Key healthcare events next week (continued)

|By:, SA News Editor

Additional presenters at the BIO CEO & Investor Conference in New York, February 12 - 13:

Akebia Therapeutics (NASDAQ:AKBA); BriaCell Therapeutics (OTCQB:BCTXF); ERYTECH Pharma (NASDAQ:ERYP); Anthera Pharmaceuticals (NASDAQ:ANTH); Summit Therapeutics (NASDAQ:SMMT); pSivida (NASDAQ:PSDV); CASI Pharmaceuticals (NASDAQ:CASI); ContraVir Pharmaceuticals (NASDAQ:CTRV) Corium (NASDAQ:CORI).

Additional presenters at SunTrust Robinson Humphrey's Orphan Drug Dayin New York on February 13: Anthera Pharmaceuticals (ANTH); Summit Therapeutics (SMMT).

Additional presenters at Leerink's Global Healthcare Conference in New York, February 14 - 15:

Epizyme (NASDAQ:EPZM); Intra-Cellular Therapies (NASDAQ:ITCI); Tocagen (NASDAQ:TOCA); Xencor (NASDAQ:XNCR); Achaogen (NASDAQ:AKAO); Forward Pharma (NASDAQ:FWP); Marinus Pharmaceuticals (NASDAQ:MRNS); Cara Therapeutics (NASDAQ:CARA); Lipocine (NASDAQ:LPCN); Intercept Pharmaceuticals (NASDAQ:ICPT); Array BioPharma (NASDAQ:ARRY); OraSure Technologies (NASDAQ:OSUR); Ardelyx (NASDAQ:ARDX); Galmed Pharmaceuticals (NASDAQ:GLMD); Bristol-Myers Squibb (NYSE:BMY); Proteostasis Therapeutics (NYSE:PTI); Acorda Therapeutics (NASDAQ:ACOR); Kura Oncology (NASDAQ:KURA); Wave Life Sciences (NASDAQ:WVE); Audentes Therapeutics (NASDAQ:BOLD); Zogenix (NASDAQ:ZGNX); Momenta Pharmaceuticals (NASDAQ:MNTA); Cardiome Pharma (NASDAQ:CRME); Ultragenyx Pharmaceutical (NASDAQ:RARE); Amgen (NASDAQ:AMGN); Align Technology (NASDAQ:ALGN); Zafgen (NASDAQ:ZFGN); Five Prime Therapeutics (NASDAQ:FPRX); Ascendis Pharma (NASDAQ:ASND); The Medicines Co. (NASDAQ:MDCO); Regulus Therapeutics (NASDAQ:RGLS); Mirati Therapeutics (NASDAQ:MRTX); Immune Design (NASDAQ:IMDZ); Trillium Therapeutics (NASDAQ:TRIL); Bruker (NASDAQ:BRKR); Cara Therapeutics (CARA); Corium (CORI).

American Academy of Dermatology: AnaptysBio (NASDAQ:ANAB): Phase 2a data on ANB020 in atopic dermatitis. Aclaris Therapeutics (NASDAQ:ACRS): Data from two Phase 3 studies of ESKATA for raised seborrheic keratoses.

Subscribe for full text news in your inbox